Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 321

1.

How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Ramos-Casals M, Kostov B, Brito-Zerón P, Sisó-Almirall A, Baughman RP; Autoimmune Big Data Study Group.

Lung. 2019 Jun 12. doi: 10.1007/s00408-019-00243-2. [Epub ahead of print] Review.

PMID:
31190130
2.

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.

Kampstra NA, Grutters JC, van Beek FT, Culver DA, Baughman RP, Renzoni EA, Wuyts W, Kouranos V, Wijsenbeek MS, Biesma DH, van der Wees PJ, van der Nat PB.

BMJ Open Respir Res. 2019 Feb 18;6(1):e000394. doi: 10.1136/bmjresp-2018-000394. eCollection 2019.

3.

Endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis: Beyond the diagnostic yield.

Trisolini R, Baughman RP, Spagnolo P, Culver DA.

Respirology. 2019 Jun;24(6):531-542. doi: 10.1111/resp.13537. Epub 2019 Mar 25. Review.

4.

Sarcoidosis Involving the Gastrointestinal Tract: Diagnostic and Therapeutic Management.

Brito-Zerón P, Bari K, Baughman RP, Ramos-Casals M.

Am J Gastroenterol. 2019 Mar 8. doi: 10.14309/ajg.0000000000000171. [Epub ahead of print]

PMID:
30865014
5.

Management of neurosarcoidosis: a clinical challenge.

Voortman M, Drent M, Baughman RP.

Curr Opin Neurol. 2019 Jun;32(3):475-483. doi: 10.1097/WCO.0000000000000684.

PMID:
30865007
6.

Sarcoidosis: patient treatment priorities.

Baughman RP, Barriuso R, Beyer K, Boyd J, Hochreiter J, Knoet C, Martone F, Quadder B, Richardson J, Spitzer G, Valeyre D, Ziosi G.

ERJ Open Res. 2018 Dec 21;4(4). pii: 00141-2018. doi: 10.1183/23120541.00141-2018. eCollection 2018 Oct.

7.

PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production.

Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, Ayers GD, Bernard GR, Culver DA, Montgomery CG, Maher TM, Molyneaux PL, Noth I, Mutsaers SE, Prele CM, Peebles RS Jr, Newcomb DC, Kaminski N, Blackwell TS, Van Kaer L, Drake WP.

Sci Transl Med. 2018 Sep 26;10(460). pii: eaar8356. doi: 10.1126/scitranslmed.aar8356.

8.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP.

JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295.

PMID:
30167654
9.

Sarcoidosis: is cryobiopsy not cool enough? - Authors' reply.

Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU.

Lancet Respir Med. 2018 Sep;6(9):e45. doi: 10.1016/S2213-2600(18)30217-0. Epub 2018 Jul 11. No abstract available.

PMID:
30007850
10.

Safety of performing transbronchial lung cryobiopsy on hospitalized patients with interstitial lung disease.

Cooley J, Balestra R, Aragaki-Nakahodo AA, Caudell Stamper DN, Sriprasart T, Swank Z, Baughman RP, Benzaquen S.

Respir Med. 2018 Jul;140:71-76. doi: 10.1016/j.rmed.2018.05.019. Epub 2018 May 25.

PMID:
29957284
11.

Response.

Baughman RP, Lower EE, Kirkil G.

Chest. 2018 Jun;153(6):1507-1508. doi: 10.1016/j.chest.2018.02.035. No abstract available.

PMID:
29884261
12.

Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis.

Pirozzi CS, Mendoza DL, Xu Y, Zhang Y, Scholand MB, Baughman RP.

Int J Environ Res Public Health. 2018 May 26;15(6). pii: E1077. doi: 10.3390/ijerph15061077.

13.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
14.

Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.

Bickett AN, Lower EE, Baughman RP.

Chest. 2018 Nov;154(5):1052-1060. doi: 10.1016/j.chest.2018.05.003. Epub 2018 May 17.

PMID:
29778660
15.

Pulmonary sarcoidosis.

Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU.

Lancet Respir Med. 2018 May;6(5):389-402. doi: 10.1016/S2213-2600(18)30064-X. Epub 2018 Apr 3. Review.

PMID:
29625772
16.

It's time to evolve from Scadding: phenotyping sarcoidosis.

Culver DA, Baughman RP.

Eur Respir J. 2018 Jan 25;51(1). pii: 1800050. doi: 10.1183/13993003.00050-2018. Print 2018 Jan. No abstract available.

PMID:
29371395
17.

Steroids for sarcoidosis: How much and for how long?

Baughman RP, Lower EE.

Respir Med. 2018 May;138S:S5-S6. doi: 10.1016/j.rmed.2017.12.009. Epub 2017 Dec 15. No abstract available.

PMID:
29276075
18.

High-Risk Sarcoidosis. Current Concepts and Research Imperatives.

Sauer WH, Stern BJ, Baughman RP, Culver DA, Royal W.

Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S437-S444. doi: 10.1513/AnnalsATS.201707-566OT. Review.

PMID:
29073361
19.

Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.

Baughman RP, Shlobin OA.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701725. doi: 10.1183/13993003.01725-2017. Print 2017 Oct. No abstract available.

20.

Higher Priced Older Pharmaceuticals: How Should We Respond?

Irwin RS, Manaker S, Metersky ML, Baughman RP, Otulana T, Weinberger SE, Sussman AJ, McGrath NA.

Chest. 2018 Jan;153(1):23-33. doi: 10.1016/j.chest.2017.09.042. Epub 2017 Oct 7.

PMID:
29017958
21.

The complimentary role of transbronchial lung cryobiopsy and endobronchial ultrasound fine needle aspiration in the diagnosis of sarcoidosis.

Aragaki-Nakahodo AA, Baughman RP, Shipley RT, Benzaquen S.

Respir Med. 2017 Oct;131:65-69. doi: 10.1016/j.rmed.2017.08.003. Epub 2017 Aug 4.

PMID:
28947045
22.

Measuring sarcoidosis around the world: Using the same ruler.

Baughman RP, Lower EE.

Rev Port Pneumol (2006). 2017 Sep - Oct;23(5):247-248. doi: 10.1016/j.rppnen.2017.08.001. Epub 2017 Aug 23. No abstract available.

23.

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site.

Lower EE, Khan S, Kennedy D, Baughman RP.

Breast Cancer (Dove Med Press). 2017 Aug 2;9:515-520. doi: 10.2147/BCTT.S137709. eCollection 2017.

24.

Sarcoidosis update: approaching the disease from multiple directions.

Baughman RP, Veltkamp M.

Curr Opin Pulm Med. 2017 Sep;23(5):432. doi: 10.1097/MCP.0000000000000411. No abstract available.

PMID:
28771452
25.

Sarcoidosis-Associated Pulmonary Hypertension.

Shlobin OA, Baughman RP.

Semin Respir Crit Care Med. 2017 Aug;38(4):450-462. doi: 10.1055/s-0037-1603767. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750460
26.

Predictors of Mortality in Pulmonary Sarcoidosis.

Kirkil G, Lower EE, Baughman RP.

Chest. 2018 Jan;153(1):105-113. doi: 10.1016/j.chest.2017.07.008. Epub 2017 Jul 18.

PMID:
28728933
27.

Chronic pulmonary aspergillosis complicating sarcoidosis.

Uzunhan Y, Nunes H, Jeny F, Lacroix M, Brun S, Brillet PY, Martinod E, Carette MF, Bouvry D, Charlier C, Lanternier F, Planès C, Tazi A, Lortholary O, Baughman RP, Valeyre D.

Eur Respir J. 2017 Jun 15;49(6). pii: 1602396. doi: 10.1183/13993003.02396-2016. Print 2017 Jun.

28.

Current concepts regarding calcium metabolism and bone health in sarcoidosis.

Baughman RP, Papanikolaou I.

Curr Opin Pulm Med. 2017 Sep;23(5):476-481. doi: 10.1097/MCP.0000000000000400. Review.

PMID:
28598871
29.

Repository corticotropin for Chronic Pulmonary Sarcoidosis.

Baughman RP, Sweiss N, Keijsers R, Birring SS, Shipley R, Saketkoo LA, Lower EE.

Lung. 2017 Jun;195(3):313-322. doi: 10.1007/s00408-017-9994-4. Epub 2017 Mar 28.

30.

Clinical characteristics of patients with bone sarcoidosis.

Zhou Y, Lower EE, Li H, Farhey Y, Baughman RP.

Semin Arthritis Rheum. 2017 Aug;47(1):143-148. doi: 10.1016/j.semarthrit.2017.02.004. Epub 2017 Feb 10.

31.

Sarcoidosis extent relates to molecular variability.

Monast CS, Li K, Judson MA, Baughman RP, Wadman E, Watt R, Silkoff PE, Barnathan ES, Brodmerkel C.

Clin Exp Immunol. 2017 Jun;188(3):444-454. doi: 10.1111/cei.12942. Epub 2017 Mar 27.

32.

Tadalafil therapy for sarcoidosis-associated pulmonary hypertension.

Ford HJ, Baughman RP, Aris R, Engel P, Donohue JF.

Pulm Circ. 2016 Dec;6(4):557-562. doi: 10.1086/688775.

33.

Challenges in diagnosing Sarcoidosis in tuberculosis endemic regions: Clinical scenario in India.

Guleria R, Mahashur A, Ghoshal AG, Thomas PK, Raghu G, Baughman RP.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):381-384.

PMID:
28079850
34.

Management of extrapulmonary sarcoidosis: challenges and solutions.

Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ.

Ther Clin Risk Manag. 2016 Nov 7;12:1623-1634. eCollection 2016. Review.

35.

Sarcoidosis: an update on current pharmacotherapy options and future directions.

Brito-Zerón P, Pérez-Alvarez R, Pallarés L, Retamozo S, Baughman RP, Ramos-Casals M; SarcoGEAS-SEMI Study Group.

Expert Opin Pharmacother. 2016 Dec;17(18):2431-2448. Review.

PMID:
27817209
36.

Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival.

Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman RP.

Chest. 2017 Jan;151(1):139-148. doi: 10.1016/j.chest.2016.08.1457. Epub 2016 Sep 8.

PMID:
27614001
37.

Sarcoidosis in America. Analysis Based on Health Care Use.

Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M, Judson MA, Wolff G.

Ann Am Thorac Soc. 2016 Aug;13(8):1244-52. doi: 10.1513/AnnalsATS.201511-760OC.

PMID:
27509154
38.

Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel.

Zhou Y, Lower EE, Li H, Baughman RP.

Respir Med Case Rep. 2015 Nov 19;17:5-7. doi: 10.1016/j.rmcr.2015.11.001. eCollection 2016.

39.

Biologic therapies in the treatment of sarcoidosis.

Saketkoo LA, Baughman RP.

Expert Rev Clin Immunol. 2016 Aug;12(8):817-25. doi: 10.1080/1744666X.2016.1175301. Epub 2016 May 3. Review.

PMID:
27117719
40.
41.

Clinical management of pulmonary sarcoidosis.

Zhou Y, Lower EE, Li H, Baughman RP.

Expert Rev Respir Med. 2016;10(5):577-91. doi: 10.1586/17476348.2016.1164602. Epub 2016 Mar 28. Review.

PMID:
26959110
42.

Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.

Baughman RP, Judson MA, Lower EE, Drent M, Costabel U, Flavin S, Lo KH, Barnathan ES; Sarcoidosis Investigators.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):289-95.

PMID:
26847095
43.

Infliximab or biosimilars in sarcoidosis; to switch or not to switch?

Veltkamp M, Drent M, Baughman RP.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):280-3. No abstract available.

PMID:
26847093
44.

A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.

Baughman RP, Barney JB, O'Hare L, Lower EE.

Respir Med. 2016 Jan;110:66-72. doi: 10.1016/j.rmed.2015.11.007. Epub 2015 Nov 19.

45.

Sarcoidosis.

Baughman RP, Culver DA.

Clin Chest Med. 2015 Dec;36(4):xv. doi: 10.1016/j.ccm.2015.09.001. No abstract available.

PMID:
26593148
46.

Pulmonary Hypertension in Sarcoidosis.

Baughman RP, Engel PJ, Nathan S.

Clin Chest Med. 2015 Dec;36(4):703-14. doi: 10.1016/j.ccm.2015.08.011. Epub 2015 Oct 9. Review.

PMID:
26593143
47.

Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response.

Krupa A, Fol M, Dziadek BR, Kepka E, Wojciechowska D, Brzostek A, Torzewska A, Dziadek J, Baughman RP, Griffith D, Kurdowska AK.

Mediators Inflamm. 2015;2015:124762. doi: 10.1155/2015/124762. Epub 2015 Aug 2.

48.

Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study.

Baughman RP, Culver DA, Jankovi V, Fischkoff S, Brockway G, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):106-14.

PMID:
26278689
49.

New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches.

Baughman RP, Grutters JC.

Lancet Respir Med. 2015 Oct;3(10):813-22. doi: 10.1016/S2213-2600(15)00199-X. Epub 2015 Jul 20. Review.

PMID:
26204816
50.

Clinical trials in pulmonary sarcoidosis.

Baughman RP, Lower EE, Saketkoo LA.

Curr Opin Pulm Med. 2015 Sep;21(5):525-31. doi: 10.1097/MCP.0000000000000193. Review.

PMID:
26176971

Supplemental Content

Loading ...
Support Center